Aroa Biosurgery
(ASX) ARX
Aroa Biosurgery Financials at a Glance
Market Cap
$183.10M
Revenue (TTM)
$100.35M
Net Income (TTM)
$3.18M
EPS (TTM)
$-0.00
P/E Ratio
-110.42
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$0.53
Volume
137,312
Open
$0.54
Price
$0.53
Volume
137,312
Open
$0.54
Previous Close
$0.53
Daily Range
$0.52 - $0.54
52-Week Range
$0.37 - $0.80
Dividend
$0.00
Beta (Volatility)
0.14 (Low)
Price
$0.53
Volume
137,312
Open
$0.54
Previous Close
$0.53
Daily Range
$0.52 - $0.54
52-Week Range
$0.37 - $0.80
ARX News
Motley Fool Moneyball Superscore
Our CEO Is Handing Members His Secret Weapon
It's called Motley Fool Moneyball, our new proprietary AI tool
We spent over half a million dollars in R&D to build a tool that makes stock research faster, sharper, and smarter. Our analysts use it every day, and now, you can too.
Get Access NowAbout Aroa Biosurgery
Industry
Biotechnology
Sector
Health CareCEO
Brian Roderick Ward, PhD, MBA
Website
www.aroa.comHeadquarters
Auckland, 2022, NZ
ARX Financials
Key Financial Metrics (TTM)
Gross Margin
85%
Operating Margin
0%
Net Income Margin
-2%
Return on Equity
-2%
Return on Capital
0%
Return on Assets
-2%
Earnings Yield
-0.91%
Dividend Yield
0.00%
Payout Ratio
0.00%
Stock Overview
Market Cap
$183.10M
Shares Outstanding
345.48M
Volume
137.31K
Short Interest
0.00%
Avg. Volume
126.98K
Financials (TTM)
Gross Profit
$65.99M
Operating Income
$8.13M
EBITDA
$2.65M
Operating Cash Flow
$2.33M
Capital Expenditure
$3.36M
Free Cash Flow
$5.69M
Cash & ST Invst.
$20.13M
Total Debt
$5.83M
Aroa Biosurgery Performance Analysis
Revenue Growth Rate
Annual and quarterly growth comparisonEarnings Per Share Growth Rate
Annual and quarterly EPS growth comparisonQuarterly Performance
Revenue
$41.08M
+129.7%
Gross Profit
$35.37M
+128.0%
Gross Margin
86.11%
N/A
Market Cap
$183.10M
N/A
Market Cap/Employee
$670.70K
N/A
Employees
273
N/A
Net Income
$1.19M
+20.8%
EBITDA
$1.61M
+208.7%
Quarterly Fundamentals
Net Cash
$14.57M
+6.2%
Accounts Receivable
$30.49M
+27.5%
Inventory
$7.09M
-15.7%
Long Term Debt
$5.02M
-7.8%
Short Term Debt
$1.12M
+33.8%
Return on Assets
-1.74%
N/A
Return on Invested Capital
0.15%
N/A
Free Cash Flow
$3.19M
+208.5%
Operating Cash Flow
$3.64M
+263.9%